Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment

Falls Prevention Through Physical And Cognitive Training (Falls PACT) in Older Adults With Mild Cognitive Impairment: A Randomised Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03167840

Acronym

FallsPACT

Enrollment

Registered

2017-05-30

Start date

2017-09-06

Completion date

2018-08-31

Last updated

2018-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

falls prevention, older adults, mild cognitive impairment

Brief summary

This randomised controlled trial aims to determine the effectiveness of combined physical and cognitive training in preventing falls and decreasing risks of falls among community-dwelling older persons with mild cognitive impairment (MCI).

Detailed description

This is a single-blind, multicentre, randomised controlled trial. Community-dwelling older adults with MCI aged 60 or above will be recruited. They will be randomly allocated into four groups: Physical Training alone (PT), Cognitive Training alone (CT), combined Physical And Cognitive Training (PACT) and wait-list group (WG). Assessors blinded to participant allocation will conduct pre-test, posttest, and 6-month follow-up assessments.

Interventions

BEHAVIORALPhysical and Cognitive Training

Physical Exercise and Cognitive Training

BEHAVIORALPhysical Training

Physical training alone

BEHAVIORALCognitive training

Cognitive training alone

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Inclusion criteria

* 60 years or above * community-dwelling in Manila, Philippines * diagnosed with MCI

Exclusion criteria

* diagnosis of dementia or Alzheimer's disease * history of major medical conditions such as cerebrovascular disease, cardiopulmonary condition, serious musculoskeletal disease, cancer, major psychiatric condition * have severe visual and/or hearing impairment * taking medications such sedatives, antidepressants, diuretics, anti-epilepsy.

Design outcomes

Primary

Measure	Time frame	Description
Falls Rate	9 months	Number of Falls over a period of time

Secondary

Measure	Time frame	Description
Change in Physiologic Profile Assessment (PPA) score	Baseline, 3 months, 9 months	Physiologic risk for falls
Change in Falls Risks for Older People in the Community (FROP-Com) Screen score	Baseline, 3 months, 9 months	Overall fall risk
Change in Global Cognitive Function	Baseline, 3 months, 9 months	Montreal Cognitive Assessment (MoCA)
Change in Memory Function	Baseline, 3 months, 9 months	Memory Index Score of the Montreal Cognitive Assessment (MoCA-MIS)
Change in Gait Speed	Baseline, 3 months, 9 months	10-Meter Walk Test (10MWT)
Change in Muscle Strength	Baseline, 3 months, 9 months	30s-Chair-Stand Test (CST)
Change in Executive Function	Baseline, 3 months, 9 months	Executive Function Performance Test (EFPT)
Change in Balance	Baseline, 3 months, 9 months	Time Up and Go Test (TUGT)

Other

Measure	Time frame	Description
Change in Fear of Falling	Baseline, 3 months, 9 months	Falls Efficacy Scale - International
Change in Quality of Life	Baseline, 3 months, 9 months	European Quality of life - five dimensions - five levels (EQ-5D-5L) questionnaire

Countries

Philippines

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026